Biogen Inc. (previously known as Biogen Idec) is an American multinational biotechnology company based in Cambridge, Massachusetts, specializing in the discovery, development, and delivery of therapies for the treatment of neurodegenerative, hematologic, and autoimmune diseases to patients worldwide. Biogen was founded in 1978 in Geneva by several prominent biologists, including Kenneth Murray of the University of Edinburgh, Phillip Allen Sharp of the Massachusetts Institute of Technology, Walter Gilbert of Harvard (who served as CEO during the start-up phase), Heinz Schaller, University of Heidelberg and Charles Weissmann, University of Zurich (who contributed the first product interferon alpha).
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely Biogen is implementing good security practices.
Read more about the latest issues in cybersecurity
In cybersecurity, an attack vector is a path or means by which an attacker can gain unauthorized ...
Formulating an IT security risk assessment methodology is a key part of building a robust ...
Compare Biogen's security performance with other companies